Drug
Alpha Proteinase Inhibitor
Alpha Proteinase Inhibitor: highest development phase Phase 2, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| Alpha-proteinase inhibitor NCT05485155 | Phase 2 | Eosinophilic Esophagitis |
Latest
No recent events.
Follow Alpha Proteinase Inhibitor on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.